MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-15-2023
Invacare Corporation Operating Income 2011-2026 | IVC
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Invacare Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -80.5 M | -24.2 M | 11.3 M | -10.4 M | -18.3 M | -40.2 M | -15.2 M | -7.77 M | -58.8 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.3 M | -80.5 M | -27.1 M |
Quarterly Operating Income Invacare Corporation
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10.4 M | - | -33.4 M | -14.8 M | -16.6 M | - | -24.8 M | -3.49 M | -5.74 M | - | 2.93 M | -2.24 M | 7.21 M | - | 2.42 M | -4.51 M | -4.48 M | - | -5.28 M | -6.76 M | -5.15 M | - | -5.88 M | -15.7 M | -10.7 M | - | 2.62 M | -5.82 M | -5.08 M | - | 189 K | -5.82 M | -4.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.21 M | -33.4 M | -7.03 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
-30.5 M | - | 1.37 % | $ 20.5 M |  USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 39.08 | -1.83 % | $ 5.82 K | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-5.13 M | $ 7.79 | 3.73 % | $ 559 M |  Israel |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.49 | -0.38 % | $ 121 M | USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 9.41 | -2.39 % | $ 1.27 B | USA |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
CONMED Corporation
CNMD
|
103 M | $ 43.34 | -5.35 % | $ 1.35 B | USA |
 |
IRIDEX Corporation
IRIX
|
-10 M | $ 1.45 | 2.84 % | $ 23.4 M | USA |
 |
IRadimed Corporation
IRMD
|
22 M | $ 104.65 | 0.88 % | $ 1.33 B | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 29.78 | -2.84 % | $ 1.37 B | USA |
 |
Apyx Medical Corporation
APYX
|
-17.3 M | $ 3.18 | -3.05 % | $ 110 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Accuray Incorporated
ARAY
|
7.84 M | $ 0.52 | -5.19 % | $ 53.4 M | USA |
 |
Pulmonx Corporation
LUNG
|
-57.7 M | $ 1.53 | - | $ 59.8 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
-9.9 M | - | 10.28 % | $ 55.5 M | Israel |
 |
Medtronic PLC
MDT
|
5.96 B | $ 96.73 | -1.38 % | $ 124 B | USA |
 |
Cytosorbents Corporation
CTSO
|
-16.8 M | $ 0.79 | 5.78 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
608 M | $ 182.92 | -3.23 % | $ 13.7 B | USA |
 |
Inari Medical
NARI
|
-28.1 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 3.73 | -3.37 % | $ 790 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
EDAP TMS S.A.
EDAP
|
-20.5 M | $ 3.96 | -3.54 % | $ 148 M |  France |
 |
Abbott Laboratories
ABT
|
8.05 B | $ 113.53 | -0.49 % | $ 198 B | USA |
 |
Nevro Corp.
NVRO
|
-126 M | - | - | $ 217 M | USA |
 |
Orthofix Medical
OFIX
|
-81.4 M | $ 13.02 | -2.62 % | $ 516 M |  Curacao |
 |
BioSig Technologies
BSGM
|
-12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 73.88 | -3.07 % | $ 109 B | USA |
 |
PAVmed
PAVM
|
-68.8 M | $ 9.94 | -0.4 % | $ 71.9 M | USA |
 |
Penumbra
PEN
|
189 M | $ 340.23 | -0.61 % | $ 13.2 B | USA |